LMAT
Lemaitre Vascular Inc Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$80.94Close
$1.8BMarket cap
$78.76 – $116.7552-week range
Nov 4, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 18 · weaker than 82% of stocks over 12 months
- Far from its high 31% below its 52-week high
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
31%
1wk
down 4.2%
price change
1mo
down 2.0%
price change
12-month return
down 8%
market up 11% ·
its own down 19%
F-score
5 / 9
Mixed
Altman Z
7.01
Low risk
P/E
31.9×
price / earnings
PEG
1.06
P/E / EPS growth
P/B
4.7×
price / book
Earnings yield
up 3.7%
EBIT / enterprise value
Cheaper than
49%
of the market · around average
Revenue growth
up 14%
year on year
EPS growth
up 15%
latest quarter · -26 pts
Sales growth
—
latest quarter
ROE
up 16%
return on equity
Free cash margin
up 30%
$74.5M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
-0.4×
net cash
Interest cover
13.1×EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- issued more shares
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- gross margin widened
Repair signals
- Gross margin 68.6% → 71.5%
Trade setup
ATR%
2.9%
$2.37 a day · 2×ATR $76.19
RS
18 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.6×
vs 50-day average
Up/down volume
0.94
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 4, 2026
Last shock
Aug 5, 2026-25% in one session5.9× volumeon results+3% since
Financials
- Gross 72%
- Net 23%
- Free cash 30%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $129.4M | $154.4M | $161.7M | $193.5M | $219.9M | $249.6M |
| Gross margin | 65% | 66% | 65% | 66% | 69% | 72% |
| Operating income | $28.8M | $36.4M | $26.8M | $36.7M | $52.3M | $67.9M |
| Net income | $21.2M | $26.9M | $20.6M | $30.1M | $44.0M | $57.7M |
| Net margin | 16% | 17% | 13% | 16% | 20% | 23% |
| Earnings per share | $1.04 | $1.25 | $0.93 | $1.34 | $1.93 | $2.52 |
| Free cash flow | $31.8M | $30.2M | $22.1M | $29.5M | $37.2M | $74.5M |
| Free cash margin | 25% | 20% | 14% | 15% | 17% | 30% |
| Cash | $26.8M | $13.9M | $19.1M | $24.3M | $25.6M | $28.2M |
| Shareholders' equity | $172.6M | $254.2M | $268.2M | $297.9M | $337.3M | $393.5M |
| Shares outstanding | 22.06m | 23.48m | 23.66m | 23.91m | 22.55m | 22.77m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 10, 2024 | Quarterly ↗ | Mar 31, 2024 | 40d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 15, 2026 | Director or officer change ↗ |
| Aug 4, 2026 | Results ↗ |
| Jun 5, 2026 | Shareholder vote ↗ |
| May 5, 2026 | Results ↗ |
| Apr 14, 2026 | Director or officer change · Other events ↗ |
| Feb 25, 2026 | Results ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 5, 2025 | Results ↗ |
| Jun 3, 2025 | Shareholder vote ↗ |
| May 1, 2025 | Results ↗ |
| Feb 27, 2025 | Results ↗ |
| Feb 13, 2025 | Director or officer change ↗ |